Compare Unichem Lab with Biocon Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs BIOCON - Comparison Results

BIOCON  
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB BIOCON UNICHEM LAB/
BIOCON
 
P/E (TTM) x 60.6 17.1 354.1% View Chart
P/BV x 0.7 2.6 24.6% View Chart
Dividend Yield % 2.1 0.4 486.2%  

Financials

 UNICHEM LAB   BIOCON
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
BIOCON
Mar-18
UNICHEM LAB/
BIOCON
5-Yr Chart
Click to enlarge
High Rs2921,188 24.6%   
Low Rs182305 59.7%   
Sales per share (Unadj.) Rs167.768.7 244.0%  
Earnings per share (Unadj.) Rs-3.67.6 -48.1%  
Cash flow per share (Unadj.) Rs5.914.0 42.5%  
Dividends per share (Unadj.) Rs4.001.00 400.0%  
Dividend yield (eoy) %1.70.1 1,259.9%  
Book value per share (Unadj.) Rs372.386.3 431.1%  
Shares outstanding (eoy) m70.38600.00 11.7%   
Bonus/Rights/Conversions ESOPIS-  
Price / Sales ratio x1.410.9 13.0%   
Avg P/E ratio x-65.398.9 -66.0%  
P/CF ratio (eoy) x39.953.4 74.6%  
Price / Book Value ratio x0.68.6 7.4%  
Dividend payout %-110.213.2 -832.0%   
Avg Mkt Cap Rs m16,680447,900 3.7%   
No. of employees `0002.66.1 42.3%   
Total wages/salary Rs m2,3939,311 25.7%   
Avg. sales/employee Rs Th4,535.26,705.8 67.6%   
Avg. wages/employee Rs Th919.81,514.2 60.7%   
Avg. net profit/employee Rs Th-98.2736.9 -13.3%   
INCOME DATA
Net Sales Rs m11,80141,234 28.6%  
Other income Rs m9842,062 47.7%   
Total revenues Rs m12,78543,296 29.5%   
Gross profit Rs m-8358,291 -10.1%  
Depreciation Rs m6743,851 17.5%   
Interest Rs m75615 12.2%   
Profit before tax Rs m-6005,887 -10.2%   
Minority Interest Rs m0213 0.0%   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-3431,569 -21.9%   
Profit after tax Rs m-2564,531 -5.6%  
Gross profit margin %-7.120.1 -35.2%  
Effective tax rate %57.326.7 214.9%   
Net profit margin %-2.211.0 -19.7%  
BALANCE SHEET DATA
Current assets Rs m20,38441,486 49.1%   
Current liabilities Rs m5,02921,413 23.5%   
Net working cap to sales %130.148.7 267.3%  
Current ratio x4.11.9 209.2%  
Inventory Days Days10564 163.8%  
Debtors Days Days13594 143.2%  
Net fixed assets Rs m9,02350,661 17.8%   
Share capital Rs m1413,000 4.7%   
"Free" reserves Rs m26,05848,808 53.4%   
Net worth Rs m26,19951,808 50.6%   
Long term debt Rs m017,898 0.0%   
Total assets Rs m31,49699,897 31.5%  
Interest coverage x-7.010.6 -66.0%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.40.4 90.8%   
Return on assets %-0.65.2 -11.1%  
Return on equity %-1.08.7 -11.2%  
Return on capital %-2.09.6 -20.8%  
Exports to sales %69.40-   
Imports to sales %00-   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,18812,058 67.9%   
Fx outflow Rs m5967,348 8.1%   
Net fx Rs m7,5924,710 161.2%   
CASH FLOW
From Operations Rs m-3,2786,621 -49.5%  
From Investments Rs m-2,860-6,840 41.8%  
From Financial Activity Rs m-24-2,397 1.0%  
Net Cashflow Rs m-4,690-2,612 179.6%  

Share Holding

Indian Promoters % 50.1 40.4 124.0%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 15.1 8.4 179.8%  
FIIs % 3.0 10.7 28.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 19.9 159.3%  
Shareholders   20,176 109,995 18.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   AUROBINDO PHARMA  PROCTER & GAMBLE HEALTH  NOVARTIS  J.B.CHEMICALS  ORCHID PHARMA LTD  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Lower; Metal and Banking Stocks Drag(09:30 am)

Asian share markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1% while the Hang Seng is up 1.1%.

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

BIOCON Announces Quarterly Results (1QFY20); Net Profit Down 11.5% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, BIOCON has posted a net profit of Rs 1 bn (down 11.5% YoY). Sales on the other hand came in at Rs 5 bn (down 57.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Sep 19, 2019 11:55 AM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS